CG Oncology Inc. Common s... (CGON)

NASDAQ: CGON · Real-Time Price · USD

29.05

1.31 (4.72%)

At close: May 02, 2025, 3:59 PM

29.05

0.00%

After-hours: May 02, 2025, 05:43 PM EDT

CG Oncology Common stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022
Net Income	-31.8M	-20.41M	-18.9M	-16.93M	-16.12M	-12.21M	-11.62M	-8.67M	-8.39M
Depreciation & Amortization	n/a	21K	7K	4K	4K	5K	4K	4K	4K
Stock-Based Compensation	4.99M	2.65M	2.25M	1.52M	778K	394K	177K	179K	148K
Other Working Capital	3.1M	3.77M	3.17M	-9.82M	780K	n/a	n/a	382K	1.12M
Other Non-Cash Items	1.25M	-1.59M	-2.48M	-2.09M	-14K	87K	621K	125K	107K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	4.9M	3.4M	3.01M	-8.4M	2.16M	618K	286K	373K	1.3M
Operating Cash Flow	-20.66M	-15.92M	-16.12M	-26.01M	-16.06M	-10.85M	-10.79M	-7.99M	-6.83M
Capital Expenditures	-209K	1K	-14K	-12K	n/a	6K	-6K	n/a	1K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-217.07M	-169.24M	-206.34M	-453.3M	-379.47M	-27.09M	-32.35M	-78.7M	-55.34M
Sales Maturities Of Investments	228.18M	201.24M	170.13M	145.87M	n/a	n/a	135.71M	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	-307.43M	16.94M	n/a	n/a	-78.7M	-55.34M
Investing Cash Flow	10.9M	32.01M	-36.23M	-307.44M	16.94M	-162.8M	103.36M	-78.7M	-55.34M
Debt Repayment	n/a	n/a	n/a	-365K	-1K	-67K	-15.39M	-833K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	355K	2.17M	40K	-3.39M	-2.89M	105.94M	165K	68K	n/a
Financial Cash Flow	223.41M	2.17M	40K	402.66M	-2.89M	105.88M	-15.22M	-765K	56.7M
Net Cash Flow	213.66M	18.25M	-52.31M	69.2M	-2.01M	-67.77M	77.35M	-87.45M	-5.47M
Free Cash Flow	-20.87M	-15.92M	-16.13M	-26.02M	-16.06M	-10.84M	-10.79M	-7.99M	-6.83M